Baumgartner E R, Wick H, Linnell J C, Gaull G E, Bachmann C, Steinmann B
Helv Paediatr Acta. 1979;34(5):483-96.
Biochemical investigations are reported in an infant with methylmalonic aciduria and homocystinuria who died at 4 months of age. Postmortem analysis of liver obtained 2 weeks after the child was treated with vitamin B12 revealed deficient activity of both cobalamin dependent enzymes: N5-methyltetrahydrofolate: homocysteine methyltransferase (requiring Me-Cbl), and methylmalonyl CoA mutase (requiring Ado-Cbl). MMA-CoA mutase activity could be restored to normal in vitro by added Ado-Cbl, but MeTHF-HCy transferase activity was not significantly enhanced by addition of Me-Cbl. Though the serum total cobalamin was normal, total cobalamin in liver and kidney was abnormally low. In the kidney Me-Cbl and Ado-Cbl were disproportionally decreased whereas in the liver only Ado-Cbl was significantly reduced. This suggests that at least some of the CN-Cbl administered was converted to the coenzymes in liver which would explain the reduction of MMA- and HCy-excretion during therapy. The results show 1. that this infant suffered from a congenital defect in one of the steps of intracellular cobalamin metabolism or transport common to the synthesis of both coenzymes, 2. that life-long treatment with vitamin B12 (OH-Cbl) may be of value in similar cases, particularly if given early in the course of the disease.
据报道,一名患有甲基丙二酸尿症和高胱氨酸尿症的婴儿在4个月大时死亡,对其进行了生化检查。在该儿童接受维生素B12治疗2周后获取的肝脏进行尸检分析,结果显示两种钴胺素依赖性酶的活性均不足:N5-甲基四氢叶酸:同型半胱氨酸甲基转移酶(需要甲基钴胺素)和甲基丙二酰辅酶A变位酶(需要腺苷钴胺素)。通过添加腺苷钴胺素,甲基丙二酰辅酶A变位酶的活性在体外可恢复正常,但添加甲基钴胺素后,N5-甲基四氢叶酸-同型半胱氨酸转移酶的活性并未显著增强。尽管血清总钴胺素正常,但肝脏和肾脏中的总钴胺素异常低。在肾脏中,甲基钴胺素和腺苷钴胺素不成比例地减少,而在肝脏中只有腺苷钴胺素显著降低。这表明至少部分给予的氰钴胺在肝脏中转化为了辅酶,这可以解释治疗期间甲基丙二酸和高胱氨酸排泄减少的原因。结果表明:1. 该婴儿在两种辅酶合成共有的细胞内钴胺素代谢或转运步骤之一中存在先天性缺陷;2. 对于类似病例,终身使用维生素B12(羟钴胺)治疗可能有价值,尤其是在疾病早期给予时。